TORRENT PHARMACEUTICALS L (TORNTPHARM)

NSE: ₹4,339.90
BSE: ₹4,337.65
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper advertisement in respect of AGM & E-voting procedure

2026-06-02 17:35:45
Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Reporting (BRSR) for FY 2025-26

2026-06-01 14:57:16
Reg. 34 (1) Annual Report.

Submission of Annual Report for FY 2025-26 and intimation of voting through electronic means

2026-06-01 14:28:57
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-05-30 11:16:19
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement - Intimation of 53rd Annual General Meeting of the Company through VC/OAVM

2026-05-28 16:06:57
2026-05-27 17:32:11
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for 2025-26

2026-05-23 14:25:36
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Audio Recording of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2026

2026-05-22 19:58:59

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 2,591.00 2,660.00 2,732.00 2,745.00 2,859.00 2,889.00 2,809.00 2,959.00 3,178.00 3,302.00 3,303.00 4,197.00
YOY Revenue Growth % 10.4% 16.11% 9.67% 10.2% 10.34% 8.61% 2.82% 7.8% 11.16% 14.3% 17.59% 41.84%
Other Income 34.00 26.00 -33.00 31.00 24.00 -16.00 33.00 -18.00 -37.00 -27.00 -13.00 -17.00
Total Income 2,625.00 2,686.00 2,699.00 2,776.00 2,883.00 2,873.00 2,842.00 2,941.00 3,141.00 3,275.00 3,290.00 4,180.00
Total Expenses + 2,094.00 2,127.00 2,156.00 2,145.00 2,227.00 2,212.00 2,151.00 2,252.00 2,403.00 2,471.00 2,466.00 3,585.00
Cost of Materials Consumed 435.00 433.00 379.00 410.00 411.00 337.00 370.00 402.00 396.00 382.00 414.00 566.00
Employee Benefit Expense 499.00 503.00 496.00 486.00 550.00 543.00 549.00 561.00 605.00 627.00 651.00 788.00
Other Expenses 651.00 672.00 670.00 697.00 711.00 729.00 673.00 703.00 767.00 792.00 765.00 1,038.00
Operating Profit 497.00 533.00 576.00 600.00 632.00 677.00 658.00 707.00 775.00 831.00 837.00 612.00
OPM % 19.2% 20% 21.1% 21.9% 22.1% 23.4% 23.4% 23.9% 24.4% 25.2% 25.3% 14.6%
Profit Before Tax + 531.00 559.00 631.00 631.00 656.00 661.00 691.00 665.00 738.00 791.00 814.00 529.00
Tax Expense 153.00 173.00 188.00 182.00 199.00 208.00 188.00 167.00 190.00 200.00 179.00 165.00
Tax % 28.8% 30.9% 29.8% 28.8% 30.3% 31.5% 27.2% 25.1% 25.7% 25.3% 22% 31.2%
Profit After Tax 378.00 386.00 443.00 449.00 457.00 453.00 503.00 498.00 548.00 591.00 635.00 364.00
EPS (Basic) 11.18 11.39 13.10 13.27 13.51 13.37 14.88 14.71 16.19 17.45 18.77 11.51

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 13,980.00 11,516.00 10,728.00 9,620.00 8,508.00 8,005.00 7,939.00
YOY Revenue Growth % 21.4% 7.35% 11.52% 13.07% 6.28% 0.83% -
Other Income -94.00 23.00 58.00 45.00 197.00 57.00 122.00
Total Income 13,886.00 11,539.00 10,786.00 9,665.00 8,705.00 8,062.00 8,061.00
Total Expenses + 10,925.00 8,842.00 8,522.00 7,818.00 6,994.00 6,536.00 4,979.00
Cost of Materials Consumed 1,758.00 1,520.00 1,657.00 1,480.00 1,538.00 1,421.00 1,377.00
Employee Benefit Expense 2,671.00 2,203.00 1,984.00 1,678.00 1,526.00 1,440.00 1,429.00
Other Expenses 3,362.00 2,816.00 2,690.00 2,365.00 2,108.00 1,933.00 2,173.00
Operating Profit 3,055.00 2,674.00 2,206.00 1,802.00 1,514.00 1,469.00 2,960.00
OPM % 21.9% 23.2% 20.6% 18.7% 17.8% 18.4% 37.3%
Profit Before Exceptional 2,961.00 2,697.00 2,264.00 1,847.00 1,711.00 1,526.00 1,187.00
Exceptional Items -89.00 -24.00 88.00 0.00 -485.00 0.00 0.00
Profit Before Tax + 2,872.00 2,673.00 2,352.00 1,847.00 1,226.00 1,526.00 1,187.00
Tax Expense 734.00 762.00 696.00 602.00 449.00 274.00 162.00
Tax % 25.6% 28.5% 29.6% 32.6% 36.6% 18% 13.6%
Profit After Tax 2,138.00 1,911.00 1,656.00 1,245.00 777.00 1,252.00 1,025.00
EPS (Basic) 63.92 56.47 48.94 36.79 45.93 73.98 60.55

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 34,919.00 9,367.00 9,450.00 9,683.00 7,805.00 8,551.00 0.00
Property, Plant & Equipment 4,909.00 3,455.00 3,297.00 2,772.00 2,703.00 2,884.00 0.00
Capital Work in Progress 457.00 367.00 281.00 688.00 544.00 745.00 0.00
Non-Current Investments 83.00 44.00 32.00 43.00 42.00 42.00 0.00
Goodwill 3,990.00 339.00 338.00 338.00 259.00 341.00 0.00
Other Intangible Assets 24,280.00 4,152.00 4,503.00 5,012.00 3,461.00 3,840.00 0.00
Current Assets + 9,392.00 5,623.00 5,611.00 5,314.00 5,165.00 5,522.00 0.00
Inventories 3,138.00 2,541.00 2,279.00 2,230.00 2,462.00 2,681.00 0.00
Trade Receivables 3,031.00 1,867.00 1,844.00 1,944.00 1,633.00 1,523.00 0.00
Cash and Cash Equivalents 1,117.00 573.00 835.00 508.00 398.00 573.00 0.00
Current Investments 866.00 112.00 141.00 156.00 184.00 139.00 0.00
LIABILITIES & EQUITY
Total Equity 17,585.00 7,591.00 6,856.00 6,198.00 5,953.00 5,838.00 0.00
Equity Share Capital 169.00 169.00 169.00 169.00 85.00 85.00 0.00
Other Equity 8,220.00 7,422.00 6,687.00 6,029.00 5,868.00 5,753.00 0.00
Non-Current Liabilities 18,384.00 2,682.00 2,779.00 3,367.00 2,732.00 3,346.00 0.00
Current Liabilities 8,343.00 4,717.00 5,426.00 5,447.00 4,415.00 4,891.00 0.00
Total Liabilities 26,727.00 7,399.00 8,205.00 8,814.00 7,147.00 8,237.00 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 3,023.00 2,585.00 3,266.00 2,368.00 1,803.00 0.00 0.00
Cash from Investing Activities -12,713.00 -540.00 -168.00 -2,356.00 -198.00 0.00 0.00
Cash from Financing Activities 10,151.00 -2,298.00 -2,779.00 77.00 -1,781.00 0.00 0.00
Net Increase/Decrease in Cash 544.00 -262.00 327.00 110.00 -175.00 0.00 0.00